Nuvama Wealth Management Approves Grant of 79.38 Lakh Employee Stock Appreciation Rights
Nuvama Wealth Management Limited has approved the grant of 79,38,556 Employee Stock Appreciation Rights (ESARs) to employees under its 2026 ESARs Scheme. The grant was approved by the Nomination and Remuneration Committee on September 1, 2026. Vesting will occur in tranches over five and four years.
The grant of ESARs is a standard employee compensation mechanism and is unlikely to have a material short-term impact on the company's financial performance or stock price. The details provided are standard for such grants.
The announcement is a routine grant of employee stock options, which is a standard compensation practice and does not inherently indicate a significant positive or negative development for the company's financial performance.
Nuvama Wealth Management Limited announced that its Nomination and Remuneration Committee (NRC), in a meeting held on September 1, 2026, approved the grant of 79,38,556 Employee Stock Appreciation Rights (ESARs) to eligible employees under the 'Nuvama Wealth Management Limited Employee Stock Appreciation Rights Scheme 2026'.
The ESARs represent stock appreciation-linked rights, and their settlement may result in the issuance of equity shares equivalent to the appreciation component over the ESAR price. The ESAR price is set at the market price of the shares on the day prior to the grant date.
Of the total ESARs granted, 73,93,366 ESARs will vest on a graded basis over five years, while the remaining 5,45,190 ESARs will vest in equal annual tranches over four years. ESAR holders can exercise their vested rights within two years from the vesting date.
A plain-language summary of a public exchange filing by Nuvama Wealth Management Limited. Read the original for the full detail.